Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02729259
Other study ID # 50416EB/002594
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 2015
Est. completion date June 2020

Study information

Verified date June 2020
Source National Institute of General Medical Sciences (NIGMS)
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is designed to find additional methods to reduce pain during wound care. In this study the investigators use virtual reality (a form of distraction) in addition to pain medication during a burn wound care.


Description:

This study will employ a randomized within-subjects design. There are three different conditions in this study. By randomization, the participants will experience at least two of the conditions and likely all three, depending on the number of their wound care sessions. All subjects will always receive all their usual pain medications for all treatment conditions. The three conditions are: High Tech Virtual Reality (VRD), Low Tech Virtual Reality (Nature Slides), and standard wound care (no VR). The subjects will be randomly assigned to receive some portions of their wound care sessions during High Tech Virtual Reality (VRD), some portions during Low Tech Virtual Reality (Nature Slides), and some portions with standard wound care, no virtual reality. The treatment orders will be randomized. After each treatment condition the investigators will ask subjects one pain question about their pain intensity during the most recent treatment condition.


Recruitment information / eligibility

Status Completed
Enrollment 56
Est. completion date June 2020
Est. primary completion date June 2020
Accepts healthy volunteers No
Gender All
Age group 8 Years and older
Eligibility Inclusion Criteria:

- Age greater than or equal to 18 years

- Compliant and able to complete questionnaires

- No history of psychiatric disorder

- Not demonstrating delirium, psychosis or any form of Organic Brain Disorder

- Able to communicate verbally

- English-speaking

Exclusion Criteria:

- Age less than 18 years

- Not capable of indicating pain intensity

- Not capable of filling out study measures

- Evidence of traumatic brain injury

- History of psychiatric disorder

- Demonstrating delirium, psychosis or any form of Organic Brain Disorder and associated memory problems

- Unable to communicate orally

- Receiving prophylaxis for alcohol or drug withdrawal

- Developmental disability

- Any face/head/neck injuries that interfere with the use of Virtual Reality equipment

- Non-English Speaking

- Extreme susceptibility to motion sickness

- Seizure history

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Virtual Reality Snowworld
The subjects will receive Virtual Reality Snowworld during their wound care procedure. The nurse will be doing their wound care.
Virtual Reality slides of nature
The subjects will receive Virtual Reality Slides of Nature during their wound care procedure. The nurse will be doing their wound care.
Control standard nurse wound care
The subjects will receive their standard care during wound care. The nurse will be doing the wound care.

Locations

Country Name City State
United States Harborview Medical Center Seattle Washington

Sponsors (2)

Lead Sponsor Collaborator
National Institute of General Medical Sciences (NIGMS) University of Washington

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary "Pain and anxiety" as measured by Graphic Rating Scale Pain and anxiety is being measured up to an hour
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05559255 - Changes in Pain, Spasticity, and Quality of Life After Use of Counterstrain Treatment in Individuals With SCI N/A
Completed NCT04748367 - Leveraging on Immersive Virtual Reality to Reduce Pain and Anxiety in Children During Immunization in Primary Care N/A
Terminated NCT04356352 - Lidocaine, Esmolol, or Placebo to Relieve IV Propofol Pain Phase 2/Phase 3
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04466111 - Observational, Post Market Study in Treating Chronic Upper Extremity Limb Pain
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05868122 - A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy Phase 3
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Completed NCT03273114 - Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain N/A
Enrolling by invitation NCT06087432 - Is PNF Application Effective on Temporomandibular Dysfunction N/A
Completed NCT05508594 - Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001 Phase 2/Phase 3
Recruiting NCT03646955 - Partial Breast Versus no Irradiation for Women With Early Breast Cancer N/A
Active, not recruiting NCT03472300 - Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
Completed NCT03678168 - A Comparison Between Conventional Throat Packs and Pharyngeal Placement of Tampons in Rhinology Surgeries N/A
Completed NCT03286543 - Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System N/A
Completed NCT03931772 - Online Automated Self-Hypnosis Program N/A
Completed NCT02913027 - Can We Improve the Comfort of Pelvic Exams? N/A
Terminated NCT02181387 - Acetaminophen Use in Labor - Does Use of Acetaminophen Reduce Neuraxial Analgesic Drug Requirement During Labor? Phase 4
Recruiting NCT06032559 - Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment Phase 3
Active, not recruiting NCT03613155 - Assessment of Anxiety in Patients Treated by SMUR Toulouse and Receiving MEOPA as Part of Their Care